多发性-话题@MedSci

#多发性#

905篇内容 | 2919人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1890384, encodeId=a290189038404, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=FDA批准vutrisiran治疗成人遗传性转甲状腺素蛋白淀粉样变性伴多发性神经病（hATTR-PN），这是第5款siRNA药物, objectType=article, longId=729775, objectId=6f41e29775b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f41e29775b5, replyNumber=0, likeNumber=84, createdTime=2022-10-31, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f41e29775b5, moduleTitle=FDA批准vutrisiran治疗成人遗传性转甲状腺素蛋白淀粉样变性伴多发性神经病（hATTR-PN），这是第5款siRNA药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f41e29775b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890360, encodeId=02c21890360b0, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=复发不再害怕，多发性骨髓瘤有了治疗新选择！, objectType=article, longId=300787, objectId=228a300e8796, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=228a300e8796, replyNumber=0, likeNumber=101, createdTime=2023-02-16, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=228a300e8796, moduleTitle=复发不再害怕，多发性骨髓瘤有了治疗新选择！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=228a300e8796)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890408, encodeId=bee31890408d9, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=欧盟批准双特异性抗体Tecvayli（teclistamab）治疗成人复发/难治性多发性骨髓瘤（RRMM）, objectType=article, longId=736911, objectId=1981e36911b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1981e36911b5, replyNumber=0, likeNumber=106, createdTime=2023-08-01, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1981e36911b5, moduleTitle=欧盟批准双特异性抗体Tecvayli（teclistamab）治疗成人复发/难治性多发性骨髓瘤（RRMM）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1981e36911b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890410, encodeId=8a9618904107d, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Neurology：波尼莫德治疗复发缓解型多发性硬化症的长期疗效, objectType=article, longId=737090, objectId=30bee3709037, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30bee3709037, replyNumber=0, likeNumber=145, createdTime=2023-05-01, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30bee3709037, moduleTitle=Neurology：波尼莫德治疗复发缓解型多发性硬化症的长期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30bee3709037)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890364, encodeId=504b18903640e, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=J Clin Oncol：B细胞成熟抗原和CD19嵌合抗原受体T细胞联合治疗多发性骨髓瘤的长期疗效, objectType=article, longId=301786, objectId=fb92301e86b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb92301e86b3, replyNumber=0, likeNumber=86, createdTime=2022-06-09, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb92301e86b3, moduleTitle=J Clin Oncol：B细胞成熟抗原和CD19嵌合抗原受体T细胞联合治疗多发性骨髓瘤的长期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb92301e86b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890353, encodeId=78701890353ad, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=LEUKEMIA：Erk1/2i 和 CDK4/6i 联合治疗复发难治性多发性骨髓瘤, objectType=article, longId=299159, objectId=5c4f2991594a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c4f2991594a, replyNumber=0, likeNumber=66, createdTime=2022-06-08, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c4f2991594a, moduleTitle=LEUKEMIA：Erk1/2i 和 CDK4/6i 联合治疗复发难治性多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c4f2991594a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890378, encodeId=34b318903e81e, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JNNP:生酮饮食治疗复发性多发性硬化症的II期研究,安全性、耐受性和潜在临床益处, objectType=article, longId=727308, objectId=ab34e27308f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab34e27308f9, replyNumber=0, likeNumber=82, createdTime=2023-04-25, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab34e27308f9, moduleTitle=JNNP:生酮饮食治疗复发性多发性硬化症的II期研究,安全性、耐受性和潜在临床益处, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab34e27308f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890415, encodeId=615d18904159c, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JNNP:那他珠单抗对多发性硬化患者工作情况的作用, objectType=article, longId=737706, objectId=5193e37706e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5193e37706e8, replyNumber=0, likeNumber=79, createdTime=2022-11-07, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5193e37706e8, moduleTitle=JNNP:那他珠单抗对多发性硬化患者工作情况的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5193e37706e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890371, encodeId=279318903e19f, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JAMA Network Open：吸烟饮酒与多发性硬化有关, objectType=article, longId=724139, objectId=2140e24139cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2140e24139cf, replyNumber=0, likeNumber=80, createdTime=2022-09-07, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2140e24139cf, moduleTitle=JAMA Network Open：吸烟饮酒与多发性硬化有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2140e24139cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890396, encodeId=29c4189039613, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=多发性肌炎的预后评判, objectType=article, longId=734238, objectId=4921e342389a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4921e342389a, replyNumber=0, likeNumber=53, createdTime=2023-03-09, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4921e342389a, moduleTitle=多发性肌炎的预后评判, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4921e342389a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890355, encodeId=822e18903554a, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JNNP:接受奥克列珠单抗治疗的多发性硬化症患者对SARS-CoV-2疫苗的免疫应答与外周免疫细胞谱的关系, objectType=article, longId=299563, objectId=a48a29956395, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a48a29956395, replyNumber=0, likeNumber=89, createdTime=2022-07-25, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a48a29956395, moduleTitle=JNNP:接受奥克列珠单抗治疗的多发性硬化症患者对SARS-CoV-2疫苗的免疫应答与外周免疫细胞谱的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a48a29956395)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890349, encodeId=9cb0189034921, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Annals of Neurology: 皮层下体积，可预测多发性硬化的易疲劳状态, objectType=article, longId=295496, objectId=b448295496d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b448295496d0, replyNumber=0, likeNumber=66, createdTime=2022-06-19, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b448295496d0, moduleTitle=Annals of Neurology: 皮层下体积，可预测多发性硬化的易疲劳状态, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b448295496d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890411, encodeId=2b9618904112a, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=J Clin Oncol：新型双特异性抗体ABBV-383在复发/难治性多发性骨髓瘤中初显疗效, objectType=article, longId=737430, objectId=dbc4e37430eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbc4e37430eb, replyNumber=0, likeNumber=121, createdTime=2023-04-22, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbc4e37430eb, moduleTitle=J Clin Oncol：新型双特异性抗体ABBV-383在复发/难治性多发性骨髓瘤中初显疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbc4e37430eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890392, encodeId=0d05189039218, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Neurology：多发性硬化患者血清神经丝轻链与视网膜内层变薄的关系, objectType=article, longId=732453, objectId=ba25e324531e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba25e324531e, replyNumber=0, likeNumber=63, createdTime=2023-05-28, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba25e324531e, moduleTitle=Neurology：多发性硬化患者血清神经丝轻链与视网膜内层变薄的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba25e324531e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890344, encodeId=393918903441e, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=European Radiology：放射组学，让多发性骨髓瘤与转移瘤的鉴别不再头疼！, objectType=article, longId=294381, objectId=87aa29438192, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87aa29438192, replyNumber=0, likeNumber=86, createdTime=2022-07-07, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87aa29438192, moduleTitle=European Radiology：放射组学，让多发性骨髓瘤与转移瘤的鉴别不再头疼！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87aa29438192)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890354, encodeId=18f218903542b, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Front Immunol：接受疾病修饰疗法的多发性硬化患者接种SARS-CoV-2疫苗后的B和T细胞应答, objectType=article, longId=299228, objectId=838729922850, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=838729922850, replyNumber=0, likeNumber=74, createdTime=2022-08-09, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=838729922850, moduleTitle=Front Immunol：接受疾病修饰疗法的多发性硬化患者接种SARS-CoV-2疫苗后的B和T细胞应答, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=838729922850)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890341, encodeId=4ccb189034163, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Haematol：达雷妥尤单抗可能用于多发性难治性自身免疫性血细胞减少症, objectType=article, longId=293385, objectId=f20f29338534, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f20f29338534, replyNumber=0, likeNumber=71, createdTime=2022-06-02, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f20f29338534, moduleTitle=Haematol：达雷妥尤单抗可能用于多发性难治性自身免疫性血细胞减少症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f20f29338534)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890373, encodeId=f97c18903e35c, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=麻醉探秘 | 多发性骨髓瘤是怎么增加局麻药全身毒性反应发生风险的, objectType=article, longId=725848, objectId=ec72e258487e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec72e258487e, replyNumber=0, likeNumber=87, createdTime=2022-12-31, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec72e258487e, moduleTitle=麻醉探秘 | 多发性骨髓瘤是怎么增加局麻药全身毒性反应发生风险的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec72e258487e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890406, encodeId=3eca1890406c7, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Neurology：OCT 标准和机器学习在多发性硬化症和视神经炎诊断中的作用, objectType=article, longId=736423, objectId=afe8e36423b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afe8e36423b8, replyNumber=0, likeNumber=80, createdTime=2022-09-24, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afe8e36423b8, moduleTitle=Neurology：OCT 标准和机器学习在多发性硬化症和视神经炎诊断中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=afe8e36423b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890402, encodeId=b7c518904023d, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=NEJM：Teclistamab治疗复发性/难治性多发性骨髓瘤, objectType=article, longId=735741, objectId=dd07e3574140, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd07e3574140, replyNumber=0, likeNumber=94, createdTime=2022-09-09, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd07e3574140, moduleTitle=NEJM：Teclistamab治疗复发性/难治性多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd07e3574140)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

多发性

2020-05-29

jml2009 (审核中...)

前往app查看评论内容

#多发性#

FDA批准vutrisiran治疗成人遗传性转甲状腺素蛋白淀粉样变性伴多发性神经病（hATTR-PN），这是第5款siRNA药物

2022-10-31

jml2009 (审核中...)

前往app查看评论内容

#多发性#

复发不再害怕，多发性骨髓瘤有了治疗新选择！

2023-02-16

jml2009 (审核中...)

前往app查看评论内容

#多发性#

欧盟批准双特异性抗体Tecvayli（teclistamab）治疗成人复发/难治性多发性骨髓瘤（RRMM）

2023-08-01

heli0118 (审核中...)

前往app查看评论内容

#多发性#

Neurology：波尼莫德治疗复发缓解型多发性硬化症的长期疗效

2023-05-01

jml2009 (审核中...)

前往app查看评论内容

#多发性#

J Clin Oncol：B细胞成熟抗原和CD19嵌合抗原受体T细胞联合治疗多发性骨髓瘤的长期疗效

2022-06-09

jml2009 (审核中...)

前往app查看评论内容

#多发性#

LEUKEMIA：Erk1/2i 和 CDK4/6i 联合治疗复发难治性多发性骨髓瘤

2022-06-08

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JNNP:生酮饮食治疗复发性多发性硬化症的II期研究,安全性、耐受性和潜在临床益处

2023-04-25

heli0118 (审核中...)

前往app查看评论内容

#多发性#

JNNP:那他珠单抗对多发性硬化患者工作情况的作用

2022-11-07

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JAMA Network Open：吸烟饮酒与多发性硬化有关

2022-09-07

智者为医08 (审核中...)

前往app查看评论内容

#多发性#

多发性肌炎的预后评判

2023-03-09

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JNNP:接受奥克列珠单抗治疗的多发性硬化症患者对SARS-CoV-2疫苗的免疫应答与外周免疫细胞谱的关系

2022-07-25

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Annals of Neurology: 皮层下体积，可预测多发性硬化的易疲劳状态

2022-06-19

heli0118 (审核中...)

前往app查看评论内容

#多发性#

J Clin Oncol：新型双特异性抗体ABBV-383在复发/难治性多发性骨髓瘤中初显疗效

2023-04-22

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Neurology：多发性硬化患者血清神经丝轻链与视网膜内层变薄的关系

2023-05-28

jml2009 (审核中...)

前往app查看评论内容

#多发性#

European Radiology：放射组学，让多发性骨髓瘤与转移瘤的鉴别不再头疼！

2022-07-07

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Front Immunol：接受疾病修饰疗法的多发性硬化患者接种SARS-CoV-2疫苗后的B和T细胞应答

2022-08-09

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Haematol：达雷妥尤单抗可能用于多发性难治性自身免疫性血细胞减少症

2022-06-02

jml2009 (审核中...)

前往app查看评论内容

#多发性#

麻醉探秘 | 多发性骨髓瘤是怎么增加局麻药全身毒性反应发生风险的

2022-12-31

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Neurology：OCT 标准和机器学习在多发性硬化症和视神经炎诊断中的作用

2022-09-24

jml2009 (审核中...)

前往app查看评论内容

#多发性#

NEJM：Teclistamab治疗复发性/难治性多发性骨髓瘤

2022-09-09

科室
- - 订阅+
  - 更多科室
工具
服务